Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Cell Based Assays

The development of robust and relevant in vitro cell based assay solutions for your drug discovery program is important to give your project the best chance of success. Our biologists can offer precisely adapted cellular assays to suit your needs and provide ongoing support in results interpretation.

Customisable Cell Assays

We have experienced cell biologists who can supply your drug discovery research program with a wide range of customisable cell based assays to help fully characterise the efficacy and safety of your discovery compounds.





Cell Based Assays Services

Cellular interaction and Co Culture Assay Systems

Assay formats that culture two or more cell types together can be used to provide a more accurate model of the target tissue environmental context. Our scientists are proficient at generating complex in vitro co-culture assays to study cellular Interaction for your particular target area, including those for vascular branching angiogenesis assays, and phagocytotic assays.


Cell Proliferation and Viability Assay

Cell health in response to drug treatment is an important factor in any drug discovery project. Our scientists routinely use assays to profile the cytostatic or cytotoxic nature of compounds using assays to detect alterations in key biomarkers involved in these processes such as ATP, caspases or DNA replication, as well as examining cell cycle progression and mitochondrial integrity.


Cell Population Analysis

We are able to provide heterogeneous cell population analysis through our capabilities in flow cytometry and high-content imaging, affording you the ability to assess cell cycle stages and the various biomarkers in response to your target treatment.


High Content Imaging and 3D Cultures

The IXM-C allows our scientists to capture high-quality images. A range of assay formats are available and are applicable to multiple phases of the drug discovery process. In addition to offering a range of formats in 2D, we are also able to screen compounds in 3D cultures. Cells cultured in 3D retain tissue architecture and cell-matrix interactions that make them display in vivo-like attributes and thus are more highly relevant in vitro models to...



The stimulus-induced migration of cells is co-ordinated tightly by complex signalling networks, and development of drugs to target these pathways are important in many therapeutic areas including tumour metastasis and wound healing. We have established chemotactic assays to quantify migrated cells in response to drug treatments.


Fibrosis Assays

Fibrosis is an abnormal accumulation of excess extracellular matrix (ECM) components around damaged tissue and can cause excessive scarring, changes in tissue structure leading to organ disease and failure. Sygnature Discovery has developed in vitro organ-specific fibrosis models using confocal microscopy, allowing high-throughput screening of potential anti-fibrotic candidates.


Intracellular Signalling

Intracellular signalling cascades are a vital network governing cell function, differentiation, and survival. We are able to offer a varied portfolio of second messenger, protein-protein interactions (PPIs), receptor internalisation, and ion channel focussed assays to elucidate the impact that your target has upon cellular signalling networks.


Phenotypic Screening

Phenotypic screens are run in many cells types and our bioscientists are expert in developing assays in primary or disease relevant primary cells in addition to immortalised lines.


Protein Expression

Analysing the expression of genes and their protein products are a vital means to understand cell functionality in response to drug exposure. Our scientists have expertise in both quantitative PCR assays and detection of analytes in single (e.g. western blot) and multiplex (e.g. AlphaLISA, Luminex and Flow Cytometry) format to evaluate the effects of your target on various signalling and expression pathways.